Podcasts about geffen school

Doctor's Farmacy with Mark Hyman, MD: Read the notes at at podcastnotes.org. Don't forget to subscribe for free to our newsletter, the top 10 ideas of the week, every Monday --------- Many people struggle with mysterious symptoms like fatigue, brain fog, food sensitivities, and skin issues—only to be misdiagnosed or dismissed altogether. This conversation highlights how histamine intolerance and mast cell activation syndrome can be the hidden drivers behind a wide range of chronic conditions, and why they're often overlooked in conventional medicine. From the role of gut health, food triggers, and environmental toxins to deeper root causes like Lyme disease or mold exposure, it's clear that personalized, Functional Medicine is key to uncovering real answers. Understanding the immune system's role in histamine reactions—and how even “healthy” foods can be inflammatory for some—is a critical step toward healing. In this episode, I talk with Dr. Todd LePine, Dr. Elizabeth Boham, and Dr. Mark Pimentel about what histamine intolerance is, how it can be related to gut health, and why it's important to address it. Dr. Todd LePine graduated from Dartmouth Medical School and is Board Certified in Internal Medicine, specializing in Integrative Functional Medicine. He is an Institute for Functional Medicine Certified Practitioner. Prior to joining The UltraWellness Center, he worked as a physician at Canyon Ranch in Lenox, MA, for 10 years. Dr. LePine's focus at The UltraWellness Center is to help his patients achieve optimal health and vitality by restoring the natural balance to both the mind and the body. His areas of interest include optimal aging, bio-detoxification, functional gastrointestinal health, systemic inflammation, autoimmune disorders, and the neurobiology of mood and cognitive disorders. Dr. LePine enjoys skiing, kayaking, hiking, camping, and golfing in the beautiful Berkshires, and is a fitness enthusiast. Dr. Elizabeth Boham is Board Certified in Family Medicine from Albany Medical School, and she is an Institute for Functional Medicine Certified Practitioner and the Medical Director of The UltraWellness Center. Dr. Boham lectures on a variety of topics, including Women's Health and Breast Cancer Prevention, insulin resistance, heart health, weight control and allergies. She is on the faculty for the Institute for Functional Medicine. Dr. Mark Pimentel is a Professor of Medicine and Gastroenterology through the Geffen School of Medicine and an Associate Professor of Medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care.  Dr. Pimentel has over 150 publications in many high-profile journals, and he is the author of the book, The Microbiome Connection: Your Guide to IBS, SIBO, and low fermentation eating. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Is Histamine Intolerance The Cause Of Your Mysterious Symptoms? What is Histamine Intolerance? Surprising Symptoms You Need to Know IBS: It's Not In Your Head—Advances In Diagnosing And Treating, Bloating And Tummy Troubles

Doctor's Farmacy with Mark Hyman, MD Key Takeaways  Histamine intolerance and mast cell activation syndrome (MCAS) can be the hidden drivers behind a wide range of chronic conditions, such as fatigue, brain fog, food sensitivities, and skin issues – yet, histamine intolerance is often overlooked by conventional medicineMCAS is a condition where certain immune cells – called mast cells – release too many chemicals (like histamine) at the wrong timesUsing diet as a short-term therapeutic tool: A low-histamine diet or Low-FODMAP Dietis not a lifelong diet because tons of healthy foods have histamine in them Consume the freshest foods possible and avoid leftovers, as histamine levels in food rise over time after preparationFoods that are traditionally categorized as “healthy” may be contributing to your histamine issues; these include: aged meats, cheeses, fermented foods, and dairy Even though they are generally healthy, consuming them is like throwing gas on your histamine fire Implementing a low-histamine diet in three phases Phase 1 – remove alcohol, especially beer, wine, and champagne Phase 2 – remove canned and smoke fish (examples: anchovies), processed and fermented meats, aged cheese, pickled and fermented foods (sauerkraut, kimchi, yogurts, kefir, mustard, ketchups, vinegar, soy sauce)   Phase 3 – remove plant foods such as spinach, avocado, tomatoes, pineapples, citrus foods Treat IBS with a low-FODMAP diet, which is specifically designed to reduce the fermentable carbohydrates that gut bacteria feed on; this helps reduce: gas production, bloating, bacterial Foods to avoid: Garlic, onions, wheat, legumes, milk, soft cheeses, apples, honey, sorbitol, xylitol, stone fruits, artificial sweetenersFoods to consume: Carrots, spinach, bananas, chicken, rice, cheddar cheese, eggsSupplement to support healthy histamine levels:Quercetin – a natural plant compound that helps people with mast cell issues, histamine intolerance, and allergies (with additional benefits to metabolic function) Read the full notes @ podcastnotes.orgMany people struggle with mysterious symptoms like fatigue, brain fog, food sensitivities, and skin issues—only to be misdiagnosed or dismissed altogether. This conversation highlights how histamine intolerance and mast cell activation syndrome can be the hidden drivers behind a wide range of chronic conditions, and why they're often overlooked in conventional medicine. From the role of gut health, food triggers, and environmental toxins to deeper root causes like Lyme disease or mold exposure, it's clear that personalized, Functional Medicine is key to uncovering real answers. Understanding the immune system's role in histamine reactions—and how even “healthy” foods can be inflammatory for some—is a critical step toward healing. In this episode, I talk with Dr. Todd LePine, Dr. Elizabeth Boham, and Dr. Mark Pimentel about what histamine intolerance is, how it can be related to gut health, and why it's important to address it. Dr. Todd LePine graduated from Dartmouth Medical School and is Board Certified in Internal Medicine, specializing in Integrative Functional Medicine. He is an Institute for Functional Medicine Certified Practitioner. Prior to joining The UltraWellness Center, he worked as a physician at Canyon Ranch in Lenox, MA, for 10 years. Dr. LePine's focus at The UltraWellness Center is to help his patients achieve optimal health and vitality by restoring the natural balance to both the mind and the body. His areas of interest include optimal aging, bio-detoxification, functional gastrointestinal health, systemic inflammation, autoimmune disorders, and the neurobiology of mood and cognitive disorders. Dr. LePine enjoys skiing, kayaking, hiking, camping, and golfing in the beautiful Berkshires, and is a fitness enthusiast. Dr. Elizabeth Boham is Board Certified in Family Medicine from Albany Medical School, and she is an Institute for Functional Medicine Certified Practitioner and the Medical Director of The UltraWellness Center. Dr. Boham lectures on a variety of topics, including Women's Health and Breast Cancer Prevention, insulin resistance, heart health, weight control and allergies. She is on the faculty for the Institute for Functional Medicine. Dr. Mark Pimentel is a Professor of Medicine and Gastroenterology through the Geffen School of Medicine and an Associate Professor of Medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care.  Dr. Pimentel has over 150 publications in many high-profile journals, and he is the author of the book, The Microbiome Connection: Your Guide to IBS, SIBO, and low fermentation eating. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Is Histamine Intolerance The Cause Of Your Mysterious Symptoms? What is Histamine Intolerance? Surprising Symptoms You Need to Know IBS: It's Not In Your Head—Advances In Diagnosing And Treating, Bloating And Tummy Troubles

Many people struggle with mysterious symptoms like fatigue, brain fog, food sensitivities, and skin issues—only to be misdiagnosed or dismissed altogether. This conversation highlights how histamine intolerance and mast cell activation syndrome can be the hidden drivers behind a wide range of chronic conditions, and why they're often overlooked in conventional medicine. From the role of gut health, food triggers, and environmental toxins to deeper root causes like Lyme disease or mold exposure, it's clear that personalized, Functional Medicine is key to uncovering real answers. Understanding the immune system's role in histamine reactions—and how even “healthy” foods can be inflammatory for some—is a critical step toward healing. In this episode, I talk with Dr. Todd LePine, Dr. Elizabeth Boham, and Dr. Mark Pimentel about what histamine intolerance is, how it can be related to gut health, and why it's important to address it. Dr. Todd LePine graduated from Dartmouth Medical School and is Board Certified in Internal Medicine, specializing in Integrative Functional Medicine. He is an Institute for Functional Medicine Certified Practitioner. Prior to joining The UltraWellness Center, he worked as a physician at Canyon Ranch in Lenox, MA, for 10 years. Dr. LePine's focus at The UltraWellness Center is to help his patients achieve optimal health and vitality by restoring the natural balance to both the mind and the body. His areas of interest include optimal aging, bio-detoxification, functional gastrointestinal health, systemic inflammation, autoimmune disorders, and the neurobiology of mood and cognitive disorders. Dr. LePine enjoys skiing, kayaking, hiking, camping, and golfing in the beautiful Berkshires, and is a fitness enthusiast. Dr. Elizabeth Boham is Board Certified in Family Medicine from Albany Medical School, and she is an Institute for Functional Medicine Certified Practitioner and the Medical Director of The UltraWellness Center. Dr. Boham lectures on a variety of topics, including Women's Health and Breast Cancer Prevention, insulin resistance, heart health, weight control and allergies. She is on the faculty for the Institute for Functional Medicine. Dr. Mark Pimentel is a Professor of Medicine and Gastroenterology through the Geffen School of Medicine and an Associate Professor of Medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care.  Dr. Pimentel has over 150 publications in many high-profile journals, and he is the author of the book, The Microbiome Connection: Your Guide to IBS, SIBO, and low fermentation eating. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Is Histamine Intolerance The Cause Of Your Mysterious Symptoms? What is Histamine Intolerance? Surprising Symptoms You Need to Know IBS: It's Not In Your Head—Advances In Diagnosing And Treating, Bloating And Tummy Troubles

A recent global poll uncovered an interesting trend in the U.S. regarding resilience. As reported by the Lloyd's Register Foundation World Risk Poll, societies tend to exhibit higher levels of resilience than the individuals within them.   Surprisingly, the survey revealed that no other country in the world has individuals as resilient as those living in a society perceived to be so fragile as the U.S. The U.S. ranks second highest in the world for individual resilience, following Sweden, in the third edition of the poll. The data was collected from 147,000 people in over 140 countries, providing insights into how individuals experienced and perceived risk in 2023.   Dr. Stephen Sideroff is a well-known psychologist, executive and medical consultant, and an expert in resilience, longevity, optimal performance, addiction, neurofeedback, and mental health. His pioneering research in these fields has been widely published. He holds the position of associate professor in the departments of Psychiatry and Biobehavioral Sciences and Rheumatology at UCLA's Geffen School of Medicine. Dr. Sideroff has played a key role in establishing innovative training and treatment approaches in optimal functioning and mind/body medicine in the U.S., China, and Europe. He has also hosted summits on longevity, resilience, and leadership.   Dr. Sideroff shares, "I had a challenging but formative childhood. The key to my success lies in my approach to overcoming the emotional difficulties I encountered. Each challenge I faced helped me grow and taught me valuable life lessons, which I now impart to my audience and network. I continue to embrace new challenges with a positive outlook, no matter how difficult they may seem, and I am eager to share my secrets to success."   For more information, visit: https://drstephensideroff.com/   To get the book, visit: https://www.amazon.com/Pillars-Resilience-Proven-Increase-Vitality/dp/1637745559/ref=sr_1_1?crid=2RK74DKQSID7K&keywords=9781637745557&qid=1702314435&s=books&sprefix=9781637745557%2Cstripbooks%2C74&sr=1-1   For inquiries, please contact: sideroff@ucla.edu

INTRODUCTION:Welcome to the Not Old Better Show Art of Living interview series. Today's show is brought to you by Qualia.  And, today we explore the fascinating stories and invaluable insights from experts dedicated to improving our lives and well-being. I'm your host, [Host Name], and today we have an exceptional guest who will guide us through the transformative journey of mastering stress, slowing aging, and increasing vitality.Our guest today is Dr. Stephen Sideroff, an internationally recognized psychologist, executive, and medical consultant with over four decades of experience in resilience, longevity, optimal performance, addiction, neurofeedback, and mental health. Dr. Sideroff is an associate professor in the departments of Psychiatry & Biobehavioral Sciences and Rheumatology at UCLA's Geffen School of Medicine. He has made pioneering contributions in his field and has been instrumental in establishing innovative training and treatment approaches across the globe, including the US, China, and Europe.Dr. Sideroff's latest book, "The 9 Pillars of Resilience: The Proven Path to Master Stress, Slow Aging, and Increase Vitality," offers a holistic methodology based on nine key pillars designed to help individuals thrive amidst overwhelming stress. In today's world, where economic uncertainty, political upheaval, international conflict, and environmental devastation weigh heavily on our minds, his insights couldn't be more timely or relevant.In this book, Dr. Sideroff draws on his extensive experience to equip us with practical techniques to adjust our minds and bodies to the demands of modern stressors. By understanding and implementing these pillars, we can not only manage stress more effectively but also enhance our overall well-being and longevity. From fostering self-compassion and positive self-talk to building supportive relationships and adopting a growth mindset, the strategies outlined in "The 9 Pillars of Resilience" are essential tools for anyone looking to live a more balanced and fulfilling life.Today, we have the privilege of diving deep into these concepts with Dr. Sideroff himself. We'll explore the evolutionary mismatches of modern stress, the critical role of self-compassion, the power of purpose, and much more. So, sit back, relax, and get ready to be inspired by Dr. Stephen Sideroff's profound knowledge and actionable insights.Dr. Stephen Sideroff, welcome to the show. We are thrilled to have you here to discuss your incredible work and the transformative power of resilience.Again, thanks for joining us today, Dr. Sideroff, on the Not Old Better Show Art of Living interview series. Today's show is brought to you by Qualia. Please support our sponosrs as they in turn support the show.  My thanks to Executive Producer Sam Heninger, for all his work with sound design and everything else.  My thanks to you our wonderful audience here on radio and podcast.  Be well, be safe and Let's Talk About Better.  The  Not Old Better Show Art of Living interview series. on radio and podcast.  Thanks, everybody and we'll see you next week.

Dr. Stephen Sideroff is an internationally recognized psychologist, executive and medical consultant and expert in resilience, longevity, optimal performance, addiction, neurofeedback, and mental health. He has published pioneering research in these fields. He is an associate professor in the departments of Psychiatry & Biobehavioral Sciences and Rheumatology at UCLA's Geffen School of Medicine. He has helped establish innovative training and treatment approaches in optimal functioning, mind/body medicine in the US, China, and Europe and hosted Summits in Longevity, Resilience and Leadership. His new book is, “The 9 Pillars of Resilience: The Proven Path to Master Stress, Slow Aging and Increase Vitality”. In this episode, we chat about:: :: his journey to identifying stress, creating workshops, and ultimately realizing our collective resistance to dealing with stress :: the concept of an optimal window of stress  :: how to find the best grounding during periods of stress :: his concept of "islands of safety" and how we can find them :: how to navigate our lives with grace :: his insights into working with medical students at UCLA on topics such as stress and the power of the placebo effect :: the difference between coming from our hearts or from a place of protecting our hearts :: his advice to C-suite executives in hospitals To find Dr. Sideroff online, go to: Instagram: @drstephensideroff Facebook: https://www.facebook.com/stephen.sideroff?mibextid=LQQJ4d TikTok: https://www.tiktok.com/@drstephensideroff LinkedIn: www.linkedin.com/in/drstephensideroff @drstephensideroffthepath5530 Website: DrStephenSideroff.com Email address: sideroff@ucla.edu   ********** To pre-order my book, "Patient, Empower Thyself!," click here.

I'm thrilled to welcome Dr. Stephen Sideroff to our podcast, Wellness at the Speed of Light. Dr. Sideroff is an internationally acclaimed psychologist, executive, and medical consultant with expertise in resilience, longevity, optimal performance, addiction, neurofeedback, and mental health. He serves as an associate professor at UCLA's Geffen School of Medicine and has founded and directed significant programs like the Stress Strategies program at UCLA/Santa Monica Hospital and the Moonview Treatment Center. His work includes pioneering research and innovative training approaches in the US, China, and Europe. Dr. Sideroff's book, "The 9 Pillars of Resilience," offers a proven path to mastering stress, slowing aging, and increasing vitality. Our discussion highlighted the beneficial aspects of stress when maintained within an optimal range, emphasizing its role in mobilization, motivation, and focus. We addressed common resistance to stress management, highlighting that stress is not inherently negative. The conversation introduced a resilience model to help individuals find their optimal stress levels for better performance and well-being. Questions for you: How do you currently manage your stress, and have you noticed any positive effects from it? What are some common reasons you or others might resist dealing with stress? How do you perceive the idea that stress can be beneficial if kept within an optimal range? Join us as we delve into Dr. Sideroff's insights and strategies to enhance well-being and resilience. This episode promises to be an enlightening and transformative experience! #DrSinicropi #StressManagement #Resilience #MentalHealth #People #WellnessattheSpeedofLight #wellness #mentalhealt #stressmanagment #stress 

What if stress isn't the enemy we thought it was? Our guest today suggests that certain aspects of stress can actually be powerful motivators. But here's the catch: there's a sweet spot, and most of us tend to overshoot it.   Today I'm speaking with Dr. Stephen Sideroff. This is a conversation you will want to listen to multiple times, or at least have a notepad with you so you can jot down some notes. In fact, you're going to want to listen to this multiple times because it's packed with incredible information and things that I think are essentials in our lives.   Dr. Sideroff is an internationally recognized expert in psychology and resilience. Not only has he published groundbreaking research, but he has served as an associate professor at UCLA's Geffen School of Medicine. Now, he's sharing his expertise in his new book, "The 9 Pillars of Resilience," offering insights into mastering stress, aging gracefully, and enhancing vitality.   In this episode, we discussed:   Why stress is the master hallmark of aging  The power of confronting unfinished emotional business in Chapter X How we can get past the discomfort of exploring our buried feelings Discovering the starting point for challenging our inner critic  Dr. Stephen Sideroff breaks down the nine pillars of resilience  How our presence can impact each other unconsciously    Connect with Dr. Stephen Sideroff   The 9 Pillars of Resilience Book   Purpose: The Ultimate in “Use It or Lose It” on Psychology Today  

Dr. Marc Schoen discusses the critical role discomfort plays in our lives—and offers powerful techniques for getting better at managing it. — YOU'LL LEARN — 1) Why we need more—not less—discomfort 2) Everyday techniques to build your discomfort tolerance 3) The 45-second trick that helps you handle stress better Subscribe or visit AwesomeAtYourJob.com/ep957 for clickable versions of the links below. — ABOUT MARC — Dr. Marc Schoen is an Assistant Clinical Professor at UCLA's Geffen School of Medicine where he specializes in Boosting Performance and Decision Making Under Pressure and Mind-Body Medicine. He works extensively with elite athletes, professional and college, as well as, executives and UCLA medical students in strengthening their ability to thrive under pressure, and in competitive and uncomfortable conditions. His method of Discomfort Training and Pilates for the Brain builds hardiness and resilience, by rewiring the fear region of the brain which is responsible for Performance Under Pressure.• Book: "Your Survival Instinct Is Killing You: Retrain Your Brain to Conquer Fear and Build Resilience" • Tool: Boosting Job Performance hypnosis audio download • Technique: The Schoen Breath Technique — RESOURCES MENTIONED IN THE SHOW — • Book: "The Comfort Crisis: Embrace Discomfort To Reclaim Your Wild, Happy, Healthy Self" by Michael Easter • Book: "The Untethered Soul: The Journey Beyond Yourself" by Michael A. Singer • App: Breathwork • Spiegel Eye Roll test demonstration video and grading chartSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode is brought to you by ARMRA, ButcherBox, and AG1. Gut health is not just about feeling your best. Your gut is the epicenter of your body and governs immune function, hormones, and nutrient absorption. Yet a whopping 74 percent of Americans claim they live with daily digestive discomfort, including suffering from constipation, which isn't just uncomfortable—it's a sign that something is wrong in the gut.In today's episode, I talk with Dhru Purohit, Dr. George Papanicolaou, and Dr. Mark Pimentel about the root causes of constipation problems and how to feel better and rebalance your gut.Dhru Purohit is a podcast host, serial entrepreneur, and investor in the health and wellness industry. His podcast, The Dhru Purohit Podcast, is a top 50 global health podcast with over 30 million unique downloads. His interviews focus on the inner workings of the brain and the body and feature the brightest minds in wellness, medicine, and mindset.Dr. George Papanicolaou is a graduate of the Philadelphia College of Osteopathic Medicine and is board certified in family medicine from Abington Memorial Hospital. He is also an Institute for Functional Medicine practitioner. In 2015, he established Cornerstone Personal Health, a practice dedicated entirely to Functional Medicine. Dr. Papanicolaou joined The UltraWellness Center in 2017.Dr. Mark Pimentel is a professor of medicine and gastroenterology through the Geffen School of Medicine and an associate professor of medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care. Dr. Pimentel has over 150 publications in many high-profile journals, and he is the author of the book The Microbiome Connection: Your Guide to IBS, SIBO, and Low-Fermentation Eating.This episode is brought to you by ARMRA, ButcherBox, and AG1.Receive 15% off your first order of ARMRA Colostrum. Go to tryarmra.com/MARK or enter MARK to get 15% off your first order.For new members of ButcherBox, you can receive New York strip steaks for a year PLUS $20 off your first order. Go to ButcherBox.com/farmacy and use code FARMACY.Head to drinkAG1.com/HYMAN to receive 10 FREE travel packs of AG1 with your first purchase.Full-length episodes of these interviews can be found here:What Is Your Constipation Telling You About Your Overall Health And How To Fix ItIBS: It's Not In Your Head—Advances In Diagnosing And Treating, Bloating And Tummy Troubles3 Things That Destroy Your Gut HealthFungus Among Us: Diagnosing And Treating Yeast Problems Hosted on Acast. See acast.com/privacy for more information.

In this episode I talk with Dr. Mark Pimentel, a leader in the small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS) world.  We talk about what his team is doing to push research forward for SIBO and IBS, new developments in SIBO, breath testing and gasses produced, as well as things that will be coming out soon for treatment.    In this episode, we cover: What is SIBO [4:29] What the team is working on [5:46] Keeping an open mind as a scientist [9:02] The controversy of breath testing [10:01] Hydrogen sulfide [13:24]   This episode is sponsored by FODZYME, the world's first enzyme blend that targets FODMAPs, gas-causing carbohydrates and common gut triggers.  Mixing FODZYME with your food allows the enzymes to integrate and break down the FODMAPs lactose, GOS, and fructan, before they can affect your gut. Through a unique formula and powder form for maximum efficacy, FODZYME can help you reduce overall FODMAP load, support better digestion and enable nutritional diversity for optimal health. Say goodbye to digestion drama with the help of FODZYME. Learn more at fodzyme.com and use code GUTSHOW at checkout to save 20% off any single order   Mentioned in this episode: REIMAGINE Study: https://csmast.com/current-research/ Breath testing for SIBO and IMO: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496284/ Research articles from the MAST team: https://csmast.com/scientific-articles/ Indian consensus statements on IBS: https://pubmed.ncbi.nlm.nih.gov/36961659/ Join the MASTER Method Membership: https://www.ibsmastermethod.com/master-method About our guest: Mark Pimentel, MD, is a Professor of Medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care. Dr. Pimentel is also a Professor of Medicine at the Geffen School of Medicine, University of California, Los Angeles (UCLA.) As a physician and researcher, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical investigations of irritable bowel syndrome (IBS) and the relationship between gut flora composition and human disease. This research led to the first ever blood tests for IBS, ibs-smartTM, the only licensed and patented serologic diagnostic for irritable bowel syndrome. The test measures the levels of two validated IBS biomarkers, anti-CdtB and anti-vinculin. A pioneering expert in IBS, Dr. Pimentel's work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel has presented at national and international medical conferences and advisory boards. He is a diplomate of the American Board of Internal Medicine (Gastroenterology,) a fellow of the Royal College of Physicians and Surgeons of Canada and a member of the American Gastroenterological Association, the American College of Gastroenterology, and the American Neurogastroenterology and Motility Society.   Learn more about Dr. Pimentel's work:  https://www.cedars-sinai.org/research/areas/science-tech.html Twitter: https://twitter.com/MASTprogram Instagram: @mastprogram   Connect with Erin & the Gutivate team: IG: @erinjudge.rd or @gutivate Website: www.gutivate.com Schedule a consult: bit.ly/gutivateconsult    FREE: IBS Fundamentals Mini Course: https://www.ibsmastermethod.com/ibs-fundamentals-sign-up   Join The GUT Community: The Facebook group for those with IBS and digestive health conditions to connect, encourage one another, and dive deeper into the topics we cover on The Gut Show. Join here: https://www.facebook.com/groups/thegutcommunity   Track your symptoms & understand your body better:  My Gut Journal is a 90 day gut tracker to build awareness in your mind & body. Get yours at https://gutivate.com/store/mygutjournal  

This episode is brought to you by Rupa Health, BiOptimizers, Sunlighten, and ARMRA.An estimated 70 million people in the United States are affected by IBS, SIBO, or another disease linked to digestive health, and 74% of Americans say they live with symptoms of digestive discomfort. Today, I'm excited to talk to Dr. Mark Pimentel about getting to the root cause of IBS and SIBO, how to properly diagnose and treat it, and strategies to improve your overall gut health.Dr. Mark Pimentel is a Professor of Medicine and Gastroenterology through the Geffen School of Medicine and an Associate Professor of Medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care. Dr. Pimentel has over 150 publications in many high-profile journals, and he is the author of the book, The Microbiome Connection: Your Guide to IBS, SIBO, and Low-Fermentation Eating.This episode is brought to you by Rupa Health, BiOptimizers, Sunlighten, and ARMRA.Access more than 3,000 specialty lab tests with Rupa Health. Check out a free, live demo with a Q&A or create an account at RupaHealth.com.This month only, get a FREE bottle of Bioptimizers Magnesium Breakthrough. Go to magbreakthrough.com/hymanfree and enter coupon code hyman10.Save up to $600 on your purchase of a Sunlighten sauna at sunlighten.com/mark-hyman and mention my name, Dr. Hyman, to save.Receive 15% off your first order of ARMRA Colostrum. Go to tryarmra.com/MARK or enter MARK to get 15% off your first order.Here are more details from our interview (audio version / Apple Subscriber version):What are IBS and SIBO and how are they different? (6:12 / 3:31)Food poisoning as the root cause of gut symptoms (9:49 / 8:05) Fungal overgrowth, or SIFO (16:00 / 12:34) Testing and treating various types of IBS (19:18 / 16:22) Low-fermentation eating (26:26 / 22:01)When probiotics worsen IBS (37:20 / 34:07) Intestinal methane overgrowth (40:08 / 36:00) The gut-brain connection (43:45 / 39:17)PCOS and gut issues (48:29 / 44:08) Mentioned in this episodeibssmart.comtriosmartbreath.comPubMed Research PapersGet a copy of The Microbiome Connection: Your Guide to IBS, SIBO, and Low-Fermentation Eating. Hosted on Acast. See acast.com/privacy for more information.

Dr. Emeran Mayer, is a gastroenterologist, a neuroscientist and distinguished professor, research professor in the Department of Medicine, Geffen School of Medicine at UCLA. He's also a Oppenheimer's Center for Neurobiology of Stress and Resilience Director, Executive Director and Founding Director of the Goodman-Lufkin Microbiome Center, also at UCLA Amarin.LINK:Emeran Mayer, MD - WebsiteEmeran Mayer - LinkedinEmeran Mayer, MD - TwitterTIMESTAMPS:00:09 - Dr. Emeran Mayer04:20 - Longevity04:46 - Gut06:45 - Healthy Lifestyle08:14 - Homeostasis11:05 - Amygdala18:31 - Acute Stress28:14 - Metabolites29:14 - Tryptophan55:33 - The Mind Gut Connection55:52 - The Gut Immune Connection56:03 - emeranmeyer.com----------#DrEmeranMayer #longevity #mircobiome #godconnectome #themindgutconnection #thegutimmuneconnection #antibiotics #IBS #brain #serotonin #robertlufkinmd #drlufkin #robertlufkin #stephensideroff #drsideroff #stephensideroffphd #healthlongevitysecrets #pathlongevity*** CHECK OUT ROB AND STEVE'S MASTERCLASSES ***Rob's MasterclassesSteve's Masterclasses*** CONNECT WITH ROBERT LUFKIN MD ON SOCIAL MEDIA ***Web: https://robertlufkinmd.com/Twitter: https://twitter.com/robertlufkinmdYoutube: https://www.youtube.com/RobertLufkinMDInstagram: https://www.instagram.com/robertlufkinmd/LinkedIn: https://www.linkedin.com/in/robertlufkinmd/*** CONNECT WITH STEPHEN SIDEROFF PHD ON SOCIAL MEDIA ***Facebook: https://www.facebook.com/stephen.sideroffTwitter: https://twitter.com/DrSideroffInstagram: https://www.instagram.com/drstephensideroff/LinkedIn: https://www.linkedin.com/in/drstephensideroff/*** SPONSORSHIPS & BRANDS ***We do work with sponsors and brands. If you are interested in working with us for your health industry product or service, please contact us at:https://pathlongevity.com/contact-us/ NOTE: This is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have. Never disregard professional medical advice or delay in seeking it because of something you have seen here. Robert Lufkin MD may at any time and at its sole discretion change or replace the information available on this channel. To the extent permitted by mandatory law, Robert Lufkin MD shall not be liable for any direct, incidental, consequential, indirect or punitive damages arising out of access to or use of any content available on this channel, including viruses, regardless of the accuracy or completeness of any such content.

Dr. Mark Pimentel is a professor of medicine and gastroenterology at Geffen School of Medicine UCLA and associate professor of medicine at Cedars-Sinai Medical Center, Los Angeles. He is also the executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai, https://csmast.com. A pioneering expert in irritable bowel syndrome (IBS), Dr. Pimentel's research led to the first-ever blood tests for IBS, https://ibssmart.com. Dr. Pimentel has served as a principal investigator for numerous clinical investigations of IBS and the relationship between gut flora composition and human disease. Dr. Pimentel is a diplomate of the American Board of Internal Medicine, a fellow of the Royal College of Physicians and Surgeons of Canada, and a member of the American Gastroenterological Association, the American College of Gastroenterology, and the American Neurogastroenterology and Motility Society. Pam Emmer is a GI motility patient who has overcome SIBO, small intestinal bacterial overgrowth. She has been a patient advocate, fundraiser and cheer leader for Cedar Sinai Medical Center in LA and the Mast Program for almost 10 years. Pam and I met with Dr. Pimentel at DDW 2023 in Chicago where we spoke about intestinal methane overgrowth, how to use prokinetics, motility and pooping - what's the difference, biomarkers for malabsorption and its relationship to SIBO and upcoming clinical trials for the MAST program.  Find Pam Emmer at: Website: https://lifeaftersibo.com Facebook: https://www.facebook.com/lifeaftersibo Twitter: https://twitter.com/lifeaftersibo Instagram: https://www.instagram.com/lifeafter_sibo Find Jeffrey Roberts and IBS Patient Support Group at: Website: https://www.ibspatient.org Facebook: https://www.facebook.com/ibspatient Twitter: https://twitter.com/ibspatient Instagram: https://www.instagram.com/ibspatient  Music: Werq Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0/

In this episode I welcome on one of my hero's in medicine, Dr. Mark Pimentel. Without hesitation, he changed my career trajectory for the better when I first came across his work in 2007. Since then he has been a mentor, adviser, and educator of me as I have dedicated myself to helping patients dealing with Irritable Bowel syndrome, Small Intestinal Bacterial Overgrowth, and Intestinal Methanogen Overgrowth. We covered so many amazing topics in this episode including: Highlights from the last 5 years of Dr. Pimentel's research His career trajectory from IBS starting as a psychosomatic disorder to know a disorder with a defined pathophysiology The latest 2021-22 research that identified the key microbes involved with hydrogen overgrowth sibo, intestinal methanogen overgrowth, and hydrogen sulfide overgrowth The role of bile acids in Irritable bowel syndrome The role of stomach acid in IBS/SIBO/IMO The role of the migrating motor complex in IBS Post-infectious Irritable bowel syndrome What makes a good GI Doctor the Medically Associated Science and Technology Program (MAST) at Cedar Sinai and more. about Dr. Pimentel: Mark Pimentel, MD, FRCP (Fellows of the Royal College of Physicians – Canada) Mark Pimentel, MD, is a Professor of Medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care. Dr. Pimentel is also a Professor of Medicine at the Geffen School of Medicine, University of California, Los Angeles (UCLA.) As a physician and researcher, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical investigations of irritable bowel syndrome (IBS) and the relationship between gut flora composition and human disease. This research led to the first ever blood tests for IBS, ibs-smart™, the only licensed and patented serologic diagnostic for irritable bowel syndrome. The test measures the levels of two validated IBS biomarkers, anti-CdtB and anti-vinculin. A pioneering expert in IBS, Dr. Pimentel's work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel has presented at national and international medical conferences and advisory boards. He is a diplomate of the American Board of Internal Medicine (Gastroenterology,) a fellow of the Royal College of Physicians and Surgeons of Canada and a member of the American Gastroenterological Association, the American College of Gastroenterology, and the American Neurogastroenterology and Motility Society. Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry at the University of Manitoba, Canada. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center in Winnipeg, Manitoba, Canada, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program. papers referenced https://journals.lww.com/ajg/pages/articleviewer.aspx?year=2022&issue=12000&article=00029&type=Fulltext https://pubmed.ncbi.nlm.nih.gov/33534012/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145321/ #ibs #sibo #imo #irritablebowelsyndrome #dysbiosis

#254 Mark Pimentel, is Professor of Medicine at Geffen School of Medicine and Cedars-Sinai Medical Center in Los Angeles. He is also the Executive Director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai Medical Center. Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program. Active in research, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical studies in such areas as IBS, and the relationship between gut flora composition and human disease. His work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel is a diplomate of the American Board of Internal Medicine (Gastroenterology) and a fellow of the Royal College of Physicians and Surgeons of Canada.   In this episode we cover Exciting new developments with SIBO research What the research says on PPI's increasing the risk of SIBO Current treatment for hydrogen sulphide treatment Why methane overgrowth (IMO) is so stubborn to treat Sibo diet post active treatment - how long to keep people on it The impact of ageing on the small intestine and the link between Scleroderma and antivinculin antibodies The preferred substrate for SIBO breath testing The Microbiome Connection book And so much more

IBS is a frustrating and difficult illness to understand.IBS is a frustrating and difficult illness to understand. But our guest led research to the first-ever blood tests for IBS, with ibs-smart®, the only licensed and patented serologic diagnostic for IBS. Mark Pimentel, MD, FRCP(C) is a professor of medicine and gastroenterology at Geffen School of Medicine UCLA and associate professor of medicine at Cedars-Sinai, Los Angeles. He is also the head of the Pimentel Laboratory and the executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai in Los Angeles and joins Marsha today to talk all about his groundbreaking research.Dr. Pimentel's decades of pioneering gastroenterological research led him to develop the Low Fermentation Eating (LFE) diet to help SIBO sufferers enjoy a less restrictive diet and lifestyle.A pioneering expert in irritable bowel syndrome (IBS), Dr. Pimentel's work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others.

In this episode, Arthur Benjamin, MD, discusses dry eye treatment and trends, the challenges dry eye patients and the eye care professionals treating them and more. Intro :37 Welcome to another episode of Eye Care insider :51 About Arthur Benjamin, MD 1:02 I wonder if you could talk about your training and what you currently do now? 1:39 Could you talk about what you've seen throughout the years and what you've seen in the trends in dry eye and how it has expanded in the population? 2:56 What is your current algorithm for someone with dry eye? How do you manage that? 5:01 Once you do determine they have moderate dry eye where do you start with the patient or the treatment paradigm? 7:00 With the OptiLight treatment option … what do you tell patients? What should they be expecting? 9:54 I recently saw that there's been a campaign from OptiLight involving Mandy Moore. Could you talk about that campaign and discuss it a little bit further? 12:54 What do you think is the most important topic or issue or challenge that are facing dry eye patients today or eye care professionals treating patients with dry eye? 16:07 What a fascinating discussion 17:43 Any last words? 17:55 Outro 18:09 Arthur Benjamin, MD, is a clinical assistant professor at the Jules Stein/Doheny Eye Institute at UCLA's Geffen School of Medicine and is in private practice at Benjamin Eye Institute.   We'd love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN. Dr. Benjamin can be contacted by going to BenjaminEye.com. Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; grant/research support from Alimera Sciences, Allergan/AbbVie, Chengdu Kanghong Biotechnology, Genentech, Notal Vision, Regeneron and Santen; consulting for Alimera Sciences, Allergan/AbbVie, Eyepoint Pharmaceuticals, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis, Regeneron and Sun Pharmaceuticals; speaker bureau for Alimera Sciences, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis and Sun Pharmaceuticals; and stock/shareholder with AbbVie and Regeneron. Benjamin reports no relevant financial disclosures.

Flavor your food with 'flavanols (flavan-3-ols)' to burn excess fat, new study suggests Dietary intake of flavanols (flavan-3-ols), type of dietary polyphenolics, could help prevent obesity by sympathetic nervous system-induced browning of fat tissue Shibaura Institute of Technology, December 13, 2021 In cold conditions, brown adipose tissue (BAT) or brown fat generates heat to keep the body warm. Compared with white adipose tissue, BAT has more mitochondria­—subcellular organelles associated with energy production—which allows it to burn calories and produce heat by activating the mitochondrial uncoupling protein 1 (Ucp-1). The stimulation of the sympathetic nervous system (SNS) after cold exposure, exercise, and calorie restriction is well known to induce fat browning. Dietary polyphenols may also activate BAT, causing heat to be dissipated from our bodies. BAT activation and white fat browning are thus both therapeutically significant in the fight against cardiovascular diseases and their comorbidities. A group of scientists examined the browning of fat induced by dietary administration of flavan 3-ols (FLs), a family of "catechin" containing polyphenols abundant in cocoa, apple, grapeseed, and red wine. In a new study published in the journal Nutrients, the team led by Professor Naomi Osakabe of Graduate School of Engineering and Science, Shibaura Institute of Technology, Japan proved that FLs enhance browning of adipose tissue by activating the SNS. The findings revealed a direct correlation between fat browning and FLs consumption, which could help researchers develop new treatments for obesity-related diseases. The authors of this study had previously discovered that a single oral dose of FLs caused fat burning and increased skeletal muscle blood flow. Here, they investigated the effects of single and multiple dose administration of FLs in mouse adipose tissue and found that FLs activate fat browning via the SNS, which secretes "catecholamine" neurotransmitters such as adrenaline (AD) and noradrenaline (NA). They fed cocoa-derived FLs to distinct groups of mice in two independent sets of experiments. One group was given a single dose of FLs, and their urine excreted over 24 hours was collected for testing. The other group received repeated doses for 14 days before being dissected for the collection of brown and white fat. All adipose samples were tested for gene and protein markers that indicate fat browning, while the urine samples were tested specifically for AD and NA levels. Higher concentrations of AD and NA in the urine following a single dose of FL clearly demonstrated SNS activation. Although the use of urine samples to evaluate SNS activation is still controversial in clinical research, it has been validated in stressed rodents. “Oral administration of FLs likely activate the SNS because they are considered stressors in these models,” explains Prof Osakabe. The team then used the obtained adipose tissue to investigate the effects of long-term FL treatment. They were thrilled to discover that the white fat of mice who were fed FLs for 14 days eventually turned brown. Some of these cells also had notable structural changes, such as “multilocular phenotype,” and appeared to be smaller than normal cells. Since BAT dissipates heat energy, does long-term FL consumption change the amounts of heat-related proteins? To answer this question, the scientists showed that Ucp-1 levels, as well as other high temperature-linked proteins, increased in mice fed repeated doses of FLs. Browning markers, referred to as "beige markers" in this study, were also abundant in these mice. “All of these proteins work together to induce the development of the BAT phenotype,” exclaims Prof. Osakabe. The team believes that the results of their study may contribute to the prevention of lifestyle-related diseases. Interestingly, this is not the first time FLs have worked wonders. Improvements in glucose and insulin tolerance have been seen after just one dose of FL-rich food administration. These findings taken together highlight the need of discussing both the acute and chronic aspects of the metabolic responses generated by FLs consumption. It is evident from this research that the SNS activity in response to FLs intake caused the observed changes in mice fat. “Although the mechanism of adipose browning is not fully understood, it is possible that repeated administration of FLs may produce browning via catecholamines and its receptors,” explains Prof. Osakabe. “Further studies will be required to understand how this process is induced by FL-rich foods,” she concludes.   Discrimination increases risk for mental health issues in young adults  University of California at Los Angeles, November 9, 2021   A UCLA study has found that young adults who have experienced discrimination have a higher risk for both short- and long-term behavioral and mental health problems. Researchers examined a decade's worth of health data on 1,834 Americans who were between 18 and 28 years old when the study began. They found that the effects of discrimination may be cumulative — that the greater number of incidents of discrimination someone experiences, the more their risk for mental and behavioral problems increases.   The study also suggests that the effects of discrimination in young adults are connected with disparities in care for mental health concerns and institutional discrimination in health care overall, including inequities in diagnoses, treatment and health outcomes. The study was published today in the journal Pediatrics. Previous studies have linked discrimination — whether due to racism, sexism, ageism, physical appearance or other biases — to a higher risk for mental illness, psychological distress and drug use. While previous research has examined the correlation in childhood or later adulthood, this new study is the first to focus on the transition to adulthood and to follow the same group of individuals over time. “With 75% of all lifetime mental health disorders presenting by age 24, the transition to adulthood is a crucial time to prevent mental and behavioral health problems,” said Yvonne Lei, a medical student at the David Geffen School of Medicine at UCLA and the study's corresponding author. Lei also said the findings are particularly relevant in light of the stresses young adults are facing nationwide today. “The COVID-19 pandemic has brought to the forefront new mental health challenges — particularly for vulnerable populations,” she said. “We have the opportunity to rethink and improve mental health services to acknowledge the impact of discrimination, so we can better address it to provide more equitable care delivery.” Researchers used data spanning 2007 to 2017 from the University of Michigan's Transition to Adulthood Supplement of the Panel Study of Income Dynamics survey. Approximately 93% of the people in the study reported experiencing discrimination; the most common factors they cited were age (26%), physical appearance (19%), sex (14%) and race (13%). The analysis showed that participants who experienced frequent discrimination, defined as a few times per month or more, were roughly 25% more likely to be diagnosed with a mental illness and twice as likely to develop severe psychological distress than those who had not experienced discrimination or had experienced it a few times per year or less. Overall, people who experienced any amount of discrimination had a 26% greater risk for poor health than people who said they did not experience discrimination. During the 10-year period, young adults in the study who had experienced multiple successive years of high-frequency discrimination showed a much more pronounced, cumulative risk for mental illness, psychological distress, drug use and worse overall health. The findings shed light on the multidimensional impact of discrimination on mental and behavioral health and overall well-being. “The associations we found are likely also intertwined with mental health care service disparities — including inequities in care access, provider biases and structural and institutional discrimination in health care — leading to inequities in diagnoses, treatment and outcomes,” said the study's senior author, Dr. Adam Schickedanz, an assistant professor of pediatrics at the Geffen School of Medicine.   Saffron: A Safe and Effective Treatment for Postpartum Depression Mashhad University of Medical Sciences (Iran)  December 11, 2021  Postpartum depression is a mood disorder that affects as many as 1 in 7 new mothers. Characterized by deep mood swings, low energy, and a loss of interest in daily activities, postpartum depression may be caused by the sudden drops in estrogen and progesterone that occur in a woman's body immediately after giving birth.[1]  Currently, the only approved medical treatments for postpartum depression are talk therapy and psychiatric medications. If a mother wishes to breastfeed, the pharmaceutical path is contraindicated due to contaminating breast milk with medication metabolites. Now, thanks to an exotic spice, there is another choice that demonstrates the power of nature to heal from within. In the journal Phytomedicine published the results of a clinical trial on saffron stigma for treating mothers suffering from postpartum depression. Saffron stigma are crimson-covered threads that are produced by the flowers of Crocus sativus L., commonly referred to as “saffron crocus.” A highly valued cooking spice, saffron is one of the world's most expensive spices by weight.[2] Beyond saffron's delicate flavor, often described as sweet and “hay like”, and rich golden hue used in traditional dyes, saffron's use as a medicinal herb has been documented for more than 4,000 years.   In this study, researchers wanted to identify a non-pharmaceutical treatment option for breastfeeding mothers suffering from mild-to-moderate postpartum depressive disorder (PPD). A double-blind, randomized, placebo-controlled trial was conducted on 60 new mothers diagnosed with PPD using the Beck Depression Inventory-Second Edition (BDI-II). Participants were randomly assigned to either saffron or placebo group, with saffron group receiving a 15-mg per day dose of the powdered herb. After 8 weeks, new BDI-II scores were taken and compared to the baseline scores. Results showed that the saffron group experienced a 96% remission rate for postpartum depression, more than double the remission rate of placebo group. BDI-II scores decreased significantly for the women consuming saffron (from 20.3 ± 5.7 to 8.4 ± 3.7), while the placebo group experienced only a modest decrease in symptom scores (19.8 ± 3.2 to 15.1 ± 5.4). Researchers concluded that saffron can have a safe and significant mood-elevating impact for those suffering from postpartum depression who want to safely breast-feed their newborns.[3] Other researchers have produced similarly encouraging findings about saffron's potential as a natural antidepressant. A 2014 meta-analysis titled “Saffron for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action” analyzed six studies on saffron for treating depression. Researchers determined conclusively that “saffron had large treatment effects” on depression. When compared with antidepressant medications, saffron was found to have similar efficacy - without the side effects.  Saffron's antidepressant properties have been attributed to its “serotonergic, antioxidant, anti-inflammatory, neuro-endocrine, and neuroprotective effects.”[4] It is a commonly held misbelief that holistic treatments for depression are only viable when a person is experiencing mild-to-moderate depression symptoms. Another meta-analysis of saffron for major depressive disorders dispels this concern. In this 2013 review of five studies on saffron for major depressive disorder, researchers noted that a “large effect” was seen in saffron-treated patients versus placebo, concluding that “saffron supplementation can improve symptoms of depression in adults with major depressive disorder.”[5] Saffron's impressive ability to elevate mood is backed-up by at least seven additional proven health benefits. Rich in B vitamins and manganese, adding this beautiful spice to your diet also provides a nutritional boost.     Regular exercise reduces the risk of and death from pneumonia, study suggests University of Bristol, December 7, 2021 People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found.  The study, led by the University of Bristol and published in GeroScience, analysed, for the first time, ten population cohort studies with over one million participants. The benefits of regular exercise are well-known and can reduce the risk, length or severity of infectious diseases. Previous research has suggested that regular exercise might be associated with a reduced risk of pneumonia, but the studies have had mixed findings with some reporting evidence of a relationship and others no evidence. The researchers carried out a pooled analysis of all published studies to re-evaluate the relationship between regular exercise and the risk of developing pneumonia. The questions the study aimed to answer included: Is there an association between regular physical activity and future risk of pneumonia? If there is an association, what is the strength and nature of the association? If there is an association, is it stronger or weaker in specific groups of people? The study found people who exercise regularly have a lower risk of developing pneumonia and pneumonia-related death compared to those who were the least or not physically active. The relationship was shown for pneumonias that did not result in death and those that resulted in death. The results did not change on taking into account known factors that can affect pneumonia such as age, sex, body mass index, socioeconomic status, alcohol consumption, smoking, and pre-existing diseases. The strength of the association did not vary by age or sex. Dr Setor Kunutsor, Senior Lecturer in Evidence Synthesis in the Bristol Medical School: Translational Health Sciences (THS) and corresponding author on the paper, said: “In this first-ever pooled analysis of all studies conducted on the topic, we found strong and convincing evidence of a relationship between regular exercise and reduction in a person's risk of developing pneumonia as well as death from the disease. "Though our study could not determine the amount and intensity of physical activity, which is essential to prevent pneumonia, some of the results suggest that walking for 30 minutes once a week has a protective effect on death due to pneumonia. “During the winter months and with COVID-19 still circulating, developing severe pneumonia from COVID-19 and other respiratory diseases is a common occurrence.  Taking regular physical activity could reduce the risk of respiratory diseases such as COVID-19 especially in at-risk groups like older adults and those with underlying health conditions.” The research does not prove cause and effect and further studies are needed to show if the associations demonstrated are causal. Also, additional work should be carried out to confirm the amount and intensity of physical activity, which is essential for the prevention of pneumonia or pneumonia-related deaths.  Finally, because regular exercise was self-reported, the values could be biased so future studies should focus on accurately assessing physical activity with the use of accelerometers or pedometers. Pneumonia is an infection of the lung tissue usually caused by bacteria or viruses and is a leading cause of death among older people, the young, and people with pre-existing health conditions. In 2016 the disease was the fourth leading cause of death in the world. Pneumonia is also associated with ill health, reduced quality of life, and high healthcare costs. Smoking, heavy drinking, respiratory conditions such as asthma, and chronic diseases such as diabetes and kidney disease, are well known to increase the risk of pneumonia, which is a preventable cause of death and disability. The study's findings add to the well documented evidence that regular physical activity has the potential to reduce the risk of several chronic diseases, infectious diseases such as pneumonia, as well as death. Physical activity has huge benefits on overall health, as well as reducing healthcare costs caused by pre-existing health conditions.   A daily dose of yoghurt could be the go-to food to manage high blood pressure University of South Australia and University of Maine, December 7, 2021 Whether it's a dollop on your morning cereal or a simple snack on the go, a daily dose of yoghurt could be the next go-to food for people with high blood pressure, according to new research from the University of South Australia. Conducted in partnership with the University of Maine, the study examined the associations between yoghurt intake, blood pressure and cardiovascular risk factors, finding that yoghurt is associated with lower blood pressure for those with hypertension. Globally, more than a billion people suffer from hypertension (high blood pressure), putting them at greater risk of cardiovascular diseases (CVDs) such as heart attack and stroke. CVDs are the leading cause of death worldwide – in the United States, one person dies from CVD every 36 seconds; in Australia, it's every 12 minutes. UniSA researcher Dr Alexandra Wade says this study provides new evidence that connects yoghurt with positive blood pressure outcomes for hypertensive people. “High blood pressure is the number one risk factor for cardiovascular disease, so it's important that we continue to find ways to reduce and regulate it,” Dr Wade says. “Dairy foods, especially yoghurt, may be capable of reducing blood pressure. “This is because dairy foods contain a range of micronutrients, including calcium, magnesium and potassium, all of which are involved in the regulation of blood pressure. “Yoghurt is especially interesting because it also contains bacteria that promote the release of proteins which lowers blood pressure. “This study showed for people with elevated blood pressure, even small amounts of yoghurt were associated with lower blood pressure. “And for those who consumed yoghurt regularly, the results were even stronger, with blood pressure readings nearly seven points lower than those who did not consume yoghurt.” The study was conducted on 915 community-dwelling adults from the Maine–Syracuse Longitudinal Study. Habitual yogurt consumption was measured using a food frequency questionnaire. High blood pressure was defined as being greater than or equal to 140/90 mmHg (a normal blood pressure level is less than 120/80 mmHg).  Researchers say that future observational and intervention studies should continue to focus on at-risk individuals to examine the potential benefits of yogurt.   Infrared sauna helps remove heavy metals and prevent cancer   University of Munich, December 13, 2021    You're about to discover the underappreciated health benefits of infrared sauna therapy. (Share this news with your healthcare provider) Every day, our bodies are besieged by toxins, including heavy metals and industrial chemicals – a non-stop bombardment that can threaten to overwhelm the body's natural defense system. In fact, the Environmental Protection Agency notes that the average American has over 700 chemicals in his or her system – including arsenic, lead, mercury, aluminum and cadmium.   The accumulation of these toxic substances can set the stage for a host of serious diseases, including cancer and dementia.  Fortunately, there is a safe and effective way to rid the body of heavy metals and other pollutants, relieving the burden on your immune system and helping to prevent and even treat cancer.   Infrared saunas detoxify and heal the body with therapeutic radiant heat   Traditional saunas, which use steam to induce sweating, require high temperatures – something many users find uncomfortable. In contrast, infrared sauna rays use radiant heat similar to that of the sun – but minus the harmful ultraviolet rays – allowing the infrared rays to penetrate the skin, heating from the inside out as well as on the surface. Experts advise temperatures of 105 to 130 degrees Fahrenheit as optimal for infrared saunas. The result is a higher comfort level and the ability to remain in the sauna longer for maximum therapeutic effects.   Cancer prevention: Infrared saunas kill mutated cancer cells   Millions of mutated cells exist in every body, but the immune system is designed to kill them off before they have a chance to multiply and grow into tumors. However, an immune system overwhelmed by toxins may not do this effectively – hence, the development of cancer. Because cancer cells have a poorer tolerance to heat than healthy cells, infrared light is just the ticket to kill them off – and stop potential cancers in their tracks. Dr Rolf Issels, M.D., Ph.D., of the University of Munich, notes that the heat produced in an infrared sauna can create “heat shock” proteins on the surfaces of cancer cells, causing them to be more vulnerable to attack by the immune system.   Heat therapy can help reduce the size of existing tumors   Research shows that heat therapy via infrared saunas activates natural killer cells, T-cells and macrophages – the body's natural cancer-fighting defense troops. Raising body heat can speed the death of tumors, as well as helping clear the body of carcinogens that contributed to their formation in the first place. Hyperthermia, or heat therapy, is acknowledged by the American Cancer Society as a “promising” way to improve cancer treatment, while the National Cancer Institute reports heat therapy has been shown to reduce tumor size is some cases. In a review published in Lancet Oncology in 2002, researchers noted that heat therapy has shown a beneficial effect in controlling certain types of cancer – such as breast cancer and malignant melanoma – and boosting survival rates in patients. But when it comes to treating cancer, an infrared sauna is not a magic bullet, or even a “single” bullet. It is merely one weapon in the cancer-fighting arsenal. Both mainstream and holistic practitioners agree: heat therapy must be combined with other forms of cancer treatment, for best results.   Infrared saunas use multiple actions to fight cancer   In addition to killing cancer cells outright, infrared saunas combat cancer by helping to improve oxygen-carrying blood flow – important because cancer cells can't thrive in high-oxygen environments. Infrared saunas also promote weight loss and fight obesity – another anti-cancer effect, due to the fact that cancer-producing hormones and carcinogens accumulate in fatty tissues. Other beneficial and chemoprotective effects of infrared sauna include increased wound healing, increased production of beneficial nitric oxide, and improved blood flow through dilation and widening of arteries.   Say “goodbye” to heavy metals and other dangerous toxins   Infrared saunas promote sweating that helps detoxify the body from heavy metals such as lead, mercury, arsenic, aluminum, cadmium and nickel – along with industrial chemicals such as pesticides and herbicides. And they do it more effectively than traditional saunas. While sweat generated in a conventional hot rock sauna has been found to consist of 95 to 97 percent water, the sweat produced by infrared saunas contains only 80 to 85 percent water. This means that the remaining 15 to 20 percent of the sweat should represent toxins that have been cleared from the system. And this fact was proven, in spades – the remainder was found to be laden with toxins such as heavy metals, sulfuric acid, uric acid and excess sodium – demonstrating that infrared saunas are more effective at eliminating toxins from the body. And, by helping toxins exit the body via the skin, infrared heat helps relieve the eliminatory and detoxifying burden on the kidneys and liver. What's the difference between far infrared and near infrared saunas? Although both have therapeutic benefits, far and near infrared have some key differences. While far infrared saunas use metallic, ceramic or black carbon elements, near infrared lamp saunas utilize 250-watt incandescent red heat lamps – the same type that can be seen heating French fries at burger outlets. In addition, near infrared sauna rays penetrate the skin to a distance of 3 inches, while far infrared rays only penetrate 1.5 inches. Proponents of near infrared saunas point to their absence of EMFs – electromagnetic frequencies – as a benefit; Although proponents of far infrared saunas acknowledge their saunas emit more EMFs, they say the effect is negligible. In the end, only you can decide which is right for you. Of course, always consult a trusted, knowledgeable holistic practitioner before using either type of sauna – especially if you suffer from a chronic disease condition. When you have the go-ahead, plan to limit your initial sessions to 20 minutes maximum to avoid dehydration, dizziness and faintness. Then, relax in the healing, soothing and detoxifying rays.

The Road to a Cure series gets on the redeye to LA to have Senior Producer and Co-host, Victoria Goldberg and co-host Kate Pfitzer speak with Dr. Sara Hurvitz. Dr. Hurvitz is the Medical Director of Clinical Researcher Unit of the Jonsson Comprehensive Cancer Center and the Director of the Breast Cancer Clinical Trials Program at UCLA, Dr. Sara Hurvitz. Dr. Hurvitz is also the Associate Professor of Medicine at the Geffen School of Medicine at UCLA.  She talks with Victoria and Kate about her perspective on where we are as we work for a cure, the HER2+ studies she is excited about, and other research that is intriguing as it relates to all subtypes. More info available on our website and sign up for our *NEW* newsblast www.ourmbclife.orgGot something to Share? Feedback?Email: ourmbclife@sharecancersupport.org Send us a voice recording via email or through speakpipe on our website.Follow on Facebook, Instagram, and Twitter @ourmbclife

Dr. Victor Gura is an associate clinical professor of medicine at the Geffen School of Medicine at UCLA. He and his company, Wearable Artificial Organs, Inc., were issued a patent for "combination wearable and stationary dialysis systems." Dr. Gura has worked 21 years in Italy and London, and finally in the United States to develop the devices. Initial clinical trials have already been conducted in Seattle, Washington. Tune in to this show to learn about the results of the trials and what the next steps are to make this invention a reality.

Dr. Michael J. Gitlin MD is Distinguished Professor of Clinical Psychiatry at the UCLA School of Medicine. He is currently the Director of the Adult Division in the Department of Psychiatry, Medical Director of the Neuropsychiatric Behavioral Health Services and Director of the Mood Disorders Clinic at the UCLA Neuropsychiatric Hospital. From 1980 until 2004, he was the Medical Director of the Aftercare Clinic, a research clinic in schizophrenia. He is the author of over 160 scientific articles and book chapters as well as five books, including: two editions of a solo authored psychopharmacology textbook written for nonphysician therapists entitled "The Psychotherapist's Guide to Psychopharmacology” published by the Free Press, the coauthor of “Psychotropic Drugs and Women” with Dr. Victoria Hendrick, the coauthor of “Clinician's Guide to Bipolar Disorder: Integrating Pharmacology with Psychotherapy”, with Dr. David Miklowitz and the coauthor of “The Essential Guide to Lithium Treatment” with Dr. Michael Bauer. He served as Chief of Staff at the Neuropsychiatric Hospital from 1997-1999. Among his awards are: Distinguished Educator Award in Teaching from the UCLA Department of Psychiatry (1999), Outstanding Housestaff Teaching Award, 1994 and 2008, Teacher of the Year from the Psychiatric Times in 2002; Dadone Clinical Teaching award from the Geffen School of Medicine at UCLA in 2010; and the Leonard Tow Humanism in Medicine award from the Geffen School of Medicine at UCLA in 2010. Today we draw from his over 40 years of clinical work and talk about the shifts of treatment of mood disorders over time.

Dr. Anne W. Rimoin, a Professor of Epidemiology at the UCLA Fielding School of Public Health and Infectious Disease Division of the Geffen School of Medicine, stops by Passing Judgment. Dr. Rimoin talks about how to prioritize who should get the vaccine, how to distribute the vaccine, how to safely re-open schools, and what a new normal looks like. This podcast is powered by Pinecast.

Some hospital workers are refusing to get vaccinated for the coronavirus. Dr. Peter Katona from UCLA's Geffen School of Medicine says it's "like beating your head against the wall" to convince people that the vaccine had gone through the right verification processes.  Los Angeles County medical facilities are running out of supplies and hospital beds. Ambulance operators are told not to bring in patients who have no chance of surviving their illnesses. Dr. Nichole Bosson from the Los Angeles County EMS Agency and USC Verdugo Hills Hospital's Keith Hobbs describe what they are seeing on the ground. Adventist Health Ukiah Valley Medical Center in Mendocino County, California managed to vaccinate 850 people in less than three hours when their freezers broke down. Dr. Bessant Parker and Judson Howe from the hospital explain how their quick thinking worked.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Some hospital workers are refusing to get vaccinated for the coronavirus. Dr. Peter Katona from UCLA's Geffen School of Medicine says it's "like beating your head against the wall" to convince people that the vaccine had gone through the right verification processes.   Los Angeles County medical facilities are running out of supplies and hospital beds. Ambulance operators are told not to bring in patients who have no chance of surviving their illnesses. Dr. Nichole Bosson from the Los Angeles County EMS Agency and USC Verdugo Hills Hospital's Keith Hobbs describe what they are seeing on the ground.  Adventist Health Ukiah Valley Medical Center in Mendocino County, California managed to vaccinate 850 people in less than three hours when their freezers broke down. Dr. Bessant Parker and Judson Howe from the hospital explain how their quick thinking worked.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Anne Rimoin is Professor of Epidemiology at the UCLA Fielding School of Public Health and Infectious Disease Division of the Geffen School of Medicine. She is also the director of the Center for Global and Immigrant Health and the director of the UCLA-DRC Health Research and Training program. She is a regular guest on the KTLA 5 Morning News and is frequently quoted in national publications and appears on national news broadcasts as an expert on the Covid-19 pandemic.During this podcast, Dr. Rimoin discusses the very latest on the pandemic and answers questions about travel, holiday gatherings, and the explosion of coronavirus cases and how people can reduce their chances of becoming infected.

UK investigators are looking into reports of coronavirus vaccine recipients having allergic reactions. Dr. Angela Rasmussen from the Georgetown Center for Global Health Science & Security says it may take a while before we know the allergic reactions are linked to the vaccine.Many of us may be tired of wearing facial coverings, but Dr. Chris Colbert from the Emergency Medicine Residency Program at the University of Illinois/Chicago says it'll take at least an year before we can interact with others without face masks. President-elect Joe Biden has announced set of plans to combat the pandemic, including a possible national mandate on facial coverings. Dr. Peter Katona from UCLA's Geffen School of Medicine offers "cautious optimism."A California small business-owner is keeping her café doors open by designating the patio area as "protest zones" to work around the State government's outdoor dining ban. Tricia Neal, who owns the Swork coffee shop in Eagle Rock, CA, says, while she doesn't blame health officials, the outdoor dining ban has been hard on her business.Americans are desperately in need of financial assistance from the second COVID relief bill. But what's holding it up in Congress? Rep. Katie Porter (D-Calif.) says Senate Majority Leader Mitch McConnell is to be blamed.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

UK investigators are looking into reports of coronavirus vaccine recipients having allergic reactions. Dr. Angela Rasmussen from the Georgetown Center for Global Health Science & Security says it may take a while before we know the allergic reactions are linked to the vaccine. Many of us may be tired of wearing facial coverings, but Dr. Chris Colbert from the Emergency Medicine Residency Program at the University of Illinois/Chicago says it'll take at least an year before we can interact with others without face masks.  President-elect Joe Biden has announced set of plans to combat the pandemic, including a possible national mandate on facial coverings. Dr. Peter Katona from UCLA's Geffen School of Medicine offers "cautious optimism." A California small business-owner is keeping her café doors open by designating the patio area as "protest zones" to work around the State government's outdoor dining ban. Tricia Neal, who owns the Swork coffee shop in Eagle Rock, CA, says, while she doesn't blame health officials, the outdoor dining ban has been hard on her business. Americans are desperately in need of financial assistance from the second COVID relief bill. But what's holding it up in Congress? Rep. Katie Porter (D-Calif.) says Senate Majority Leader Mitch McConnell is to be blamed.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

There's so much happening regarding COVID right now, so we figured we should check in with an expert and try to get facts on how to be smart and stay safe these days. Dr. Anne Rimoin is a leading epidemiologist and expert in pandemics, having worked in public health on ebola virus for years. She’s a Professor of Epidemiology at the UCLA Fielding School of Public Health and Infectious Disease Division of the Geffen School of Medicine. Anne is the Director of the Center for Global and Immigrant Health and is an expert on emerging infections, global health, surveillance systems, and vaccination. She's also currently leading several studies of COVID-19.Anne talked all things COVID. She told Hilaria and Daphne about when she thinks the vaccine will roll out, how/why masks work, and that they do help, and she gives context by discussing history. Anne gives us lots to think about, and was honest and open about the scientific community not doing a great job at communicating with the public, and that any and every question from the public is valid and should be answered. Plus a very welcomed dose of optimism, that we WILL get through this.Favorite Things:Daphne: Caraway Home cooking productsHilaria: Pure Enrichment productsAnne: Face ShieldsEmail us with your questions at mombrainpod@gmail.com and follow us on Instagram, just search for @MomBrain. We answer a lot of your questions on there! Check out videos of our episodes on our YouTube channel! We also invite you to become a member of Mom Brain's official Facebook Group.

With me today is Dr. Mark Pimentel who really needs no introduction to the SIBO community. He's the executive director of the MAST program or Medically Associated Science and Technology. He's professor of medicine at Geffen School of Medicine at Cedar-Sinai Medical Center in L.A. A few of Dr. Pimentel's most significant accomplishments include the discovery of rifaximin as a treatment for IBS. He also developed the first blood test for IBS based on IBS being derived from acute gastroenteritis; the antibody testing. He described the association between IBS and bacterial overgrowth, which forms the basis of microbiome therapies in this condition, as well as uncovering that methanogens are causing constipations in humans.

Dr. Anne Rimoin is a top U.S. epidemiologist and professor of UCLA Fielding School of Public Health and Infectious Disease Division of the Geffen School of Medicine. She has published 70 research articles and book chapters. Her work has been featured in The New York Times, The Atlantic, The Economist, The Wall Street Journal, The Washington Post, WIRED, Discover, Scientific American, Popular Science, Forbes, National Geographic, Nature, and Science. Dr. Rimoin was recently inducted as a fellow of the American Society of Tropical Medicine and Hygiene. I wasn’t about to waste such an opportunity, so I gathered every question I could think of about coronavirus testing, vaccination, and public policy and pressed the record button. This is one of the most important episodes of Remarkable People that you could listen to because it could literally save your life.

Mottek On Money Special Edition covering Wall Street and Main Street during the coronavirus crisis: The election week stock market rally continues sending all of the major averages near record highs as the presidential election vote count continued in battleground states. The Dow closed up another 543 points, Nasdaq gained 300 and the SP500 ended up 67. Analysis on the markets and the economy from money manager Ken Winans, President, Winans Investments and Economist Kevin Klowden, executive director of the Milken Institute's Center for Regional Economics and California Center. Theresa Miller, CIO, Lionsgate and 2020 Chair of  Innovate@UCLA discusses technology's impact during the pandemic and the 2020 Innovate@UCLA virtual leadership awards on November 12th at 530pm https://www.eventbrite.com/e/innovateucla-executive-leadership-awards-virtual-event-tickets-119294821021 for the first time the event is free and open to the business community https://innovateucla.org/  Dr. Anne Rimoin, Professor of Epidemiology at the UCLA Fielding School of Public Health and Infectious Disease Division of the Geffen School of Medicine updates the Los Angeles business community on the pandemic.  Support the show: https://www.frankmottek.com See omnystudio.com/listener for privacy information.

Frequent international travels help Dr. Vanessa Ngakeng with her understanding of patients, their needs, cultures, and backgrounds. She is fluent in English, Spanish, Bamileke, and French. During her collegiate career, Dr. Ngakeng was a competitive tennis player and she still enjoys the game today. Dr. Ngakeng received her medical degree from The Geffen School of Medicine at UCLA/Charles R. Drew University and completed her residency in ophthalmology at the Howard University Medical Center Department of Ophthalmology. Dr. Ngakeng completed a cornea / refractive fellowship at Corneal Consultants of Indiana/Price Vision Group. Dr. Ngakeng is highly recognized, having received the Charles R. Drew University of Medicine and Sciences Ophthalmology Award, Howard University Achievement Award, and the Outstanding Surgical Intern of the Year Award from California Hospital, Los Angeles. She has authored and published numerous articles and participated in several medical studies. Dr. Ngakeng is highly recognized, having received the Charles R. Drew University of Medicine and Sciences Ophthalmology Award, Howard University Achievement Award, and the Outstanding Surgical Intern of the Year Award from California Hospital, Los Angeles. She has authored and published numerous articles and participated in several medical studies. s a cornea specialist, Dr. Ngakeng cares for diseases and conditions involving the cornea and corneal injuries. She performs refractive corneal procedures including LASIK and is a highly experienced cataract surgeon offering advanced implant lenses for the correction of presbyopia and astigmatism. Contact Dr. Vanessa Ngakeng: http://vanessangakengmd.com/ What is your biggest obstacle to creating an incredible life? You can book a free 15-minute mentoring session with Dr. Kimberley Linert. Click on this booking link: https://calendly.com/drkimberley/15min Please subscribe to the podcast and take a few minutes to review on iTunes, Thank you If you have an amazing story to tell about your life and how you are sharing your gifts and talents with the world, then I would love to have you as a guest on my podcast. Contact me via email: incrediblelifepodcast@gmail.com or private message me on Facebook: www.facebook.com/incrediblelifecreator www.DrKimberleyLinert.com

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Sara Hurvitz, MD, Associate Professor of Medicine, Geffen School of Medicine, UCLA, Medical Director, Jonsson Comprehensive Cancer Center Clinical Research Unit, discuss breast cancer patient types, challenges, and treatment advances.

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Sara Hurvitz, MD, Associate Professor of Medicine, Geffen School of Medicine, UCLA, Medical Director, Jonsson Comprehensive Cancer Center Clinical Research Unit, discuss breast cancer patient types, challenges, and treatment advances

Dr. Marc Schoen has specialized in Mind-Body Medicine for over 25 years. He is an Assistant Clinical Professor at UCLA's Geffen School of Medicine where he specializes in Boosting Performance and Decision Making Under Pressure and Mind-Body Medicine. He works extensively with elite athletes, professional and college, as well as, executives and UCLA medical students in strengthening their ability to thrive under pressure, and in competitive and uncomfortable conditions. His method of Discomfort Training and Pilates for the Brain builds hardiness and resilience, by rewiring the fear region of the brain which is responsible for Performance Under Pressure.   Dr. Marc Schoen American Society of Clinical Hypnosis

Dillon Dejam is a rising third-year medical student at UCLA's Geffen School of Medicine and is highly active on social media providing motivation and mentorship for premed students. In this episode, we discuss Dillon's journey to medical school, his best tips for premeds, and common issues premeds struggle with.  Follow him here: Twitter: @medschooldillon IG: @medschooldillon TikTok: @medschooldillon YouTube: Dillon Dejam Podcast: Dillon Dejam Mentorship Podcast 

When was the last time you cleaned your credit or debit cards? Or the remote for the TV? There are a lot of things around the house you never think to clean – but you will after you hear this. https://www.fitandfabliving.com/general-health/6435-seven-surprisingly-dirty-surfaces/How spiritual are you? Psychiatrist Dr. Anna Yusim, author of the book Fulfilled: How the Science of Spirituality Can Help You Live a Happier, More Meaningful Life (http://amzn.to/2tglpsf), discusses what it means to be spiritual and what recent scientific research says about the benefits of spirituality both for your health and happiness.Don’t you hate it when you grab a pen to write something and no ink comes out? I’ll tell you what the experts say to get the ink flowing again quickly. https://www.wikihow.com/Restart-a-Dry-Ball-Point-PenThere’s a problem with your survival instinct. Dr. Marc Schoen, Assistant Clinical Professor at UCLA’s Geffen School of Medicine and author of the book, Your Survival Instinct is Killing You (http://amzn.to/2uK7sHw) explains how our survival instinct was meant to keep us safe from imminent danger – like a lion who wants to eat you. But today, we don’t need it for that. Consequently, that instinct can cause problems if we don’t learn to regulate it. It can cause us to act inappropriately and can take a toll on our health. So he explains how to manage that instinct and turn down the intensity.

The Maurice Kelley Memorial Lecture Medicine Grand Rounds February 28, 2020 Mark Pimentel, MD, FRCP(C) Executive Director, Medically Associated Science and Technology (MAST) Program Professor of Medicine, Geffen School of Medicine Cedars-Sinai Medical Center Associate Medical Director, Clinical Microbiology, Brigham and Women’s Hospital, Harvard Medical School

#130 Mark Pimentel, is Professor of Medicine at Geffen School of Medicine and Cedars-Sinai Medical Center in Los Angeles. He is also the Executive Director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai Medical Center.  Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program.  Active in research, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical studies in such areas as IBS, and the relationship between gut flora composition and human disease. His work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others.  Dr. Pimentel is a diplomate of the American Board of Internal Medicine (Gastroenterology) and a fellow of the Royal College of Physicians and Surgeons of Canada.  In this episode we cover The link between autoimmunity and SIBO The IBS smart test Hydrogen sulphide SIBO including assessment, treatment  Prokinetics - how long, who for Why excess weight may be common in methane dominant SIBO Is the lactulose or glucose breath test better for determining SIBO And so much more

Today I'm speaking with Dr. Mark Pimentel and of course, he's no stranger to anyone in the SIBO community. He's been really instrumental in many IBS and SIBO studies and a lot of research that's been happening over the last few years.   I learned about Dr. Pimentel through his book, The New IBS Solution, about 10 years ago. He is the executive director of the Medically Associated Science and Technology program at Cedars-Sinai. He's a professor of medicine at Geffen School of Medicine and associate professor of Cedars-Sinai Medical Center in Los Angeles. He's very active in research and has served as a principal investigator or co-investigator for numerous clinical studies. And of course we know him as the developer or discoverer of  the anti-vinculin and anti-CdtB antibodies that predict whether or not you have SIBO or autoimmune IBS. He also discovered the use of Lovastatin for methanogens.   

Today I'm speaking with Dr. Mark Pimentel and of course, he's no stranger to anyone in the SIBO community. He's been really instrumental in many IBS and SIBO studies and a lot of research that's been happening over the last few years.   I learned about Dr. Pimentel through his book, The New IBS Solution, about 10 years ago. He is the executive director of the Medically Associated Science and Technology program at Cedars-Sinai. He's a professor of medicine at Geffen School of Medicine and associate professor of Cedars-Sinai Medical Center in Los Angeles. He's very active in research and has served as a principal investigator or co-investigator for numerous clinical studies. And of course we know him as the developer or discoverer of  the anti-vinculin and anti-CdtB antibodies that predict whether or not you have SIBO or autoimmune IBS. He also discovered the use of Lovastatin for methanogens.   

In this episode we speak with Dr. Mark Pimentel about Small Intestinal Bacterial Overgrowth (SIBO). Dr. Pimentel is Professor of Medicine, Geffen School of Medicine and Associate Professor at Cedars‐Sinai Medical Center in Los Angeles, California. Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry at the University of Manitoba, Canada. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center in Winnipeg, Manitoba, Canada, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program. Active in research, Dr. Pimentel has served as a principal investigator or co‐investigator for numerous basic‐science, translational and clinical studies in such areas as IBS, and the relationship between gut flora composition and human disease. His work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterologyand Digestive Diseases and Sciences, among others. Dr. Pimentel has been invited to present his work at meetings, grand rounds and advisory boards in the United States and Internationally. He is diplomate of the American Board of Internal Medicine (Gastroenterology) and a fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Pimentel is also a member of several medical associations including the American Gastroenterological Association, the American College of Gastroenterology, and the American Neurogastroenterology and Motility Society. Learning Points: • Benefits of shopping local • What is SIBO? • What are signs and symptoms of SIBO? • How is SIBO treated? Social Media https://twitter.com/MarkPimentelMD https://www.cedars-sinai.edu/Research/Research-Labs/Pimentel-Lab/

EP12: USC Radio - Dr. Daphna Gans Jack has a chance to sit down with Dr. Daphna Gans, who is not only a school board member, but also an esteemed researcher at UCLA's Geffen School of Medicine. Dr. Gans on Linkedin: https://www.linkedin.com/in/daphna-gans-727b0023/ Intro music by Pittsburgh's own New Invisible Joy; outro music by Useless ID, a killer punk band from Israel. USC Radio is made possible in part via a grant from the Community Foundation of Upper St. Clair. Visit www.cfUSC.org.

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Edward Garon, MD, Associate Professor of Medicine, Geffen School of Medicine at UCLA, discuss lung cancer highlights from ASCO 2019.

We'd love to hear from you with ideas, suggestions, feedback, and questions for Dr. Henry or Dr. Yurkeiwicz at podcasts@mdedge.com and you can follow MDedge Hematology/Oncology at @MDedgeHemOnc.   Blood & Cancer episode 10:CDK4/6 inhibitors in breast cancer Richard Finn, MD, of the Geffen School of Medicine at UCLA joins guest host Jame Abraham, MD, of the Cleveland Clinic to discuss CDK4/6 inhibitors in the treatment of breast cancer, from the first pivotal studies to efficacy and patient selection. Later, Ilana Yurkiewicz, MD, talks about why it’s problematic to tell patients there is no more treatment in this week’s Clinical Correlation. Dr. Yurkiewicz is a fellow in hematology and oncology at Stanford University and is also a columnist for Hematology News.   Show notes By Emily Bryer, DO, Resident in the department of internal medicine, University of Pennsylvania. Cyclin dependent kinase 4 and 6 (CDK4/6) control phosphorylation of the retinoblastoma gene product in the G1 to S transition of the cell cycle. Luminal ER-positive HER2-negative breast cancers are most sensitive to inhibition with a CDK4/6 inhibitor and act synergistically with tamoxifen. PALOMA 1 trial studied CDK4/6 Inhibitors in ER-positive breast cancer. Letrozole alone (10-month PFS) versus letrozole plus palbociclib (greater than 20-month PFS) Toxicity = grade 3 (ANC 500-1000) and grade 4 neutropenia (ANC less than 500) Low incidence of neutropenic fever Palbociclib and chemotherapy have distinct effects on the bone marrow. Palbociclib is cytostatic (also, toxicity is predictable and not cumulative) Chemotherapy is cytocidal Although efficacy is similar between CDK4/6 inhibitors (PFS hazard ratio +/-0.5), side effects vary. Ribociclib and palbociclib have a higher incidence of neutropenia Ribociclib affects QTC interval and liver enzymes Abemaciclib is associated with diarrhea and venous thromboembolism Ongoing studies are exploring 1) CDK4/6 inhibitor plus endocrine therapy versus endocrine therapy alone and 2) CDK4/6 inhibitors in the adjuvant setting. The population to most benefit from CDK4/6 inhibitors may include the patients who are high-risk for relapse following endocrine therapy alone (previously those who would also receive chemotherapy). Additional reading N Engl J Med 2018; 379:1926-36. Breast Cancer. 2018 Jul;25(4):402-6.

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Richard Finn, MD, Professor of Medicine at the Geffen School of Medicine, UCLA, discuss hepatocellular carcinoma (HCC) clinical highlights from ASCO GI 2019

Mark Pimentel, M.D., is Professor of Medicine, Geffen School of Medicine and Associate Professor at Cedars-Sinai Medical Center in Los Angeles, California. Rebecca joined him live at Cedars-Sinai in Los Angeles to speak to him about his research into Hydrogen Sulphide SIBO.The difference between IBS & SIBO, and what comes first? IBS or SIBO?What is Hydrogen Sulphide SIBO and how is it different from Hydrogen and Methane SIBO?How do you test for Hydrogen Sulphide SIBO? When will it be available and where?Why a traditional SIBO breath test would show a flatline result if a patient has Hydrogen Sulphide SIBO?Why Hydrogen can look falsely negative when Hydrogen Sulphide or Methane is present?Why Hydrogen takes 60 minutes to be produced and longer for MethaneWhy Hydrogen is not a reliable gas on SIBO breath testsShould patients be asking for Hydrogen and Methane breath tests?Why some people have a high baseline reading – how does this happen?What the methanogens are (ie. M. Smithi)? And what produces Hydrogen and Hydrogen Sulphide?Why and how methane slows intestinal transit time?If methane SIBO is more likely to cause weight gain, does that mean Hydrogen SIBO is more likely to cause weight loss? What does it mean for Hydrogen Sulphide SIBO regarding weight?How do you clinically handle the SIBO patient who has lost significant amounts of weight and can’t regain it? What’s your advice for SIBO patients who are gaining unwanted weight?Can you have 1, 2 or 3 of the gases present at the same time? If so, what’s the correlation between the gasses?What are the symptoms of Hydrogen Sulphide SIBO in comparison to the other types of SIBO? And how do the symptoms change depending on the presence of the other gases?What are the treatments for Hydrogen Sulphide SIBO? Are there any treatments/supplements Hydrogen Sulphide SIBO patients should avoid?Does the diet need to be modified any differently for Hydrogen Sulphide SIBO than the commonly used SIBO diets?Should we be staying on a low FODMAP/SIBO diet long term? What are the risks if we do? What do you see clinically works for your patients who don’t respond to traditional SIBO treatments (potentially multiple rounds of all currently available treatment options)?How important is it for us to identify the underlying cause(s) of SIBO? What should a patient do if they can’t identify an underlying cause?How can we test our MMC and transit time? How important is it to know this?Watch the video recording of the interview here: https://zoom.us/recording/play/mIOWPAiaRiQjVshBf-vs-4EPo7blkFwSIaw8v9HjBEyuvuuaPszjq8b1NzXMEJ6l Support this show http://supporter.acast.com/thehealthygut. See acast.com/privacy for privacy and opt-out information.

Salespeople have ever increasing quotas, growing competition, and new products and features to add to our bag of tricks. There are countless opportunities for that little twinge of fear: presenting in front of a crowd, reaching out to new prospects, getting pitted against that competitor you wish you knew more about...the list goes on. Marc Schoen, Ph.D. is an Assistant Clinical Professor at UCLA's Geffen School of Medicine where he specializes in Boosting Performance and Decision Making Under Pressure. He's literally the expert on how to be a top performer and set yourself apart from your competitiors. In this episode of #SalesJOLT, you'll learn: - How to be bulletproof under pressure, conflict, and competition, - Exercises to increase your discomfort threshold, - What it takes to make better decisions, be more productive, improve performance, AND your health AND MORE...

Vivian Burt MD, professor emeritus of psychiatry and founder/director of the Women's Life Center at the Geffen School of Medicine (UCLA), describes the science of menopause, the role of estrogen, the clinical presentations, psychiatric risk factors, role of body weight, etc, and treatments for menopause